HARROW, INC.

HROW Nasdaq CIK: 0001360214

Company Information

Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 1A BURTON HILLS BLVD, NASHVILLE, TN,
Mailing Address 1A BURTON HILLS BLVD, NASHVILLE, TN,
Phone 615.733.4731
Fiscal Year End 1231
EIN 450567010

Financial Overview

FY2025

$347.39M
Total Liabilities
$-0.49
EPS

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events March 27, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment March 27, 2026 View on SEC
8-K Current report of material events March 24, 2026 View on SEC
8-K Current report of material events March 24, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) March 11, 2026 View on SEC
8-K Current report of material events March 10, 2026 View on SEC
4 Insider stock transaction report March 5, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
10-K Annual financial report March 2, 2026 View on SEC
8-K Current report of material events March 2, 2026 View on SEC

Annual Reports

10-K March 2, 2026
  • Achieved solid revenue growth of 25% to $150 million, primarily driven by strategic acquisitions.
  • Returned to profitability with a net income of $10 million ($0.50 per diluted share), a significant improvement from a prior year net loss.
View Analysis

Insider Trading

STRONG SELL 1 insiders 6 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2834)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.